EDWARDS LIFESCIENCES CORP (EWL.DE) Fundamental Analysis & Valuation

FRA:EWL • US28176E1082

Current stock price

71.45 EUR
-1.72 (-2.35%)
Last:

This EWL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. EWL.DE Profitability Analysis

1.1 Basic Checks

  • In the past year EWL was profitable.
  • In the past year EWL had a positive cash flow from operations.
  • Each year in the past 5 years EWL has been profitable.
  • In the past 5 years EWL always reported a positive cash flow from operatings.
EWL.DE Yearly Net Income VS EBIT VS OCF VS FCFEWL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

  • With an excellent Return On Assets value of 7.84%, EWL belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 10.38%, EWL is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
  • EWL has a Return On Invested Capital of 12.01%. This is amongst the best in the industry. EWL outperforms 87.30% of its industry peers.
  • EWL had an Average Return On Invested Capital over the past 3 years of 13.04%. This is above the industry average of 9.72%.
Industry RankSector Rank
ROA 7.84%
ROE 10.38%
ROIC 12.01%
ROA(3y)18.26%
ROA(5y)18.16%
ROE(3y)24.41%
ROE(5y)25.04%
ROIC(3y)13.04%
ROIC(5y)15.54%
EWL.DE Yearly ROA, ROE, ROICEWL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • With an excellent Profit Margin value of 17.69%, EWL belongs to the best of the industry, outperforming 93.65% of the companies in the same industry.
  • EWL's Profit Margin has been stable in the last couple of years.
  • With an excellent Operating Margin value of 27.17%, EWL belongs to the best of the industry, outperforming 93.65% of the companies in the same industry.
  • In the last couple of years the Operating Margin of EWL has declined.
  • EWL has a Gross Margin of 78.01%. This is amongst the best in the industry. EWL outperforms 90.48% of its industry peers.
  • In the last couple of years the Gross Margin of EWL has remained more or less at the same level.
Industry RankSector Rank
OM 27.17%
PM (TTM) 17.69%
GM 78.01%
OM growth 3Y-8.34%
OM growth 5Y-1.77%
PM growth 3Y-19.64%
PM growth 5Y-1.18%
GM growth 3Y-2.35%
GM growth 5Y0.69%
EWL.DE Yearly Profit, Operating, Gross MarginsEWL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

10

2. EWL.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EWL is creating some value.
  • Compared to 1 year ago, EWL has less shares outstanding
  • The number of shares outstanding for EWL has been reduced compared to 5 years ago.
  • Compared to 1 year ago, EWL has an improved debt to assets ratio.
EWL.DE Yearly Shares OutstandingEWL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
EWL.DE Yearly Total Debt VS Total AssetsEWL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 11.23 indicates that EWL is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 11.23, EWL belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
  • EWL has a debt to FCF ratio of 0.45. This is a very positive value and a sign of high solvency as it would only need 0.45 years to pay back of all of its debts.
  • The Debt to FCF ratio of EWL (0.45) is better than 95.24% of its industry peers.
  • EWL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • EWL has a better Debt to Equity ratio (0.06) than 90.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.45
Altman-Z 11.23
ROIC/WACC1.2
WACC10.02%
EWL.DE Yearly LT Debt VS Equity VS FCFEWL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • EWL has a Current Ratio of 3.72. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of EWL (3.72) is better than 92.06% of its industry peers.
  • EWL has a Quick Ratio of 3.09. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 3.09, EWL belongs to the best of the industry, outperforming 92.06% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.72
Quick Ratio 3.09
EWL.DE Yearly Current Assets VS Current LiabilitesEWL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. EWL.DE Growth Analysis

3.1 Past

  • The earnings per share for EWL have decreased by -2.29% in the last year.
  • Measured over the past 5 years, EWL shows a small growth in Earnings Per Share. The EPS has been growing by 6.67% on average per year.
  • EWL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.86%.
  • The Revenue has been growing slightly by 6.70% on average over the past years.
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
Revenue 1Y (TTM)10.86%
Revenue growth 3Y10.77%
Revenue growth 5Y6.7%
Sales Q2Q%13.26%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.89% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 9.72% on average over the next years. This is quite good.
EPS Next Y17.7%
EPS Next 2Y14.8%
EPS Next 3Y14.07%
EPS Next 5Y12.89%
Revenue Next Year10.66%
Revenue Next 2Y10.22%
Revenue Next 3Y10.13%
Revenue Next 5Y9.72%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EWL.DE Yearly Revenue VS EstimatesEWL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
EWL.DE Yearly EPS VS EstimatesEWL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

2

4. EWL.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 32.04, the valuation of EWL can be described as expensive.
  • EWL's Price/Earnings ratio is in line with the industry average.
  • EWL's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 25.71.
  • EWL is valuated quite expensively with a Price/Forward Earnings ratio of 27.21.
  • 63.49% of the companies in the same industry are cheaper than EWL, based on the Price/Forward Earnings ratio.
  • EWL is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.83, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 32.04
Fwd PE 27.21
EWL.DE Price Earnings VS Forward Price EarningsEWL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EWL is valued a bit more expensive than the industry average as 65.08% of the companies are valued more cheaply.
  • EWL's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 35.67
EV/EBITDA 23.66
EWL.DE Per share dataEWL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EWL does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of EWL may justify a higher PE ratio.
  • A more expensive valuation may be justified as EWL's earnings are expected to grow with 14.07% in the coming years.
PEG (NY)1.81
PEG (5Y)4.8
EPS Next 2Y14.8%
EPS Next 3Y14.07%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EWL.DE Dividend Analysis

5.1 Amount

  • No dividends for EWL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EWL.DE Fundamentals: All Metrics, Ratios and Statistics

EDWARDS LIFESCIENCES CORP

FRA:EWL (3/13/2026, 7:00:00 PM)

71.45

-1.72 (-2.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)04-21
Inst Owners91.12%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap41.50B
Revenue(TTM)6.07B
Net Income(TTM)1.07B
Analysts79.53
Price Target81.61 (14.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.39%
Min EPS beat(2)-8.84%
Max EPS beat(2)9.63%
EPS beat(4)3
Avg EPS beat(4)2.32%
Min EPS beat(4)-8.84%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)1.48%
EPS beat(12)5
Avg EPS beat(12)0.35%
EPS beat(16)7
Avg EPS beat(16)-0.13%
Revenue beat(2)1
Avg Revenue beat(2)-0.31%
Min Revenue beat(2)-1.47%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.84%
Revenue beat(12)2
Avg Revenue beat(12)-2.11%
Revenue beat(16)2
Avg Revenue beat(16)-2.28%
PT rev (1m)-1.5%
PT rev (3m)-0.09%
EPS NQ rev (1m)5.87%
EPS NQ rev (3m)6.38%
EPS NY rev (1m)1.35%
EPS NY rev (3m)2.47%
Revenue NQ rev (1m)1.79%
Revenue NQ rev (3m)1.48%
Revenue NY rev (1m)0.85%
Revenue NY rev (3m)0.85%
Valuation
Industry RankSector Rank
PE 32.04
Fwd PE 27.21
P/S 7.85
P/FCF 35.67
P/OCF 29.85
P/B 4.61
P/tB 6.4
EV/EBITDA 23.66
EPS(TTM)2.23
EY3.12%
EPS(NY)2.63
Fwd EY3.67%
FCF(TTM)2
FCFY2.8%
OCF(TTM)2.39
OCFY3.35%
SpS9.1
BVpS15.51
TBVpS11.16
PEG (NY)1.81
PEG (5Y)4.8
Graham Number27.9
Profitability
Industry RankSector Rank
ROA 7.84%
ROE 10.38%
ROCE 13.87%
ROIC 12.01%
ROICexc 18.64%
ROICexgc 29.98%
OM 27.17%
PM (TTM) 17.69%
GM 78.01%
FCFM 22%
ROA(3y)18.26%
ROA(5y)18.16%
ROE(3y)24.41%
ROE(5y)25.04%
ROIC(3y)13.04%
ROIC(5y)15.54%
ROICexc(3y)18.54%
ROICexc(5y)20.56%
ROICexgc(3y)28.25%
ROICexgc(5y)29.44%
ROCE(3y)15.07%
ROCE(5y)17.95%
ROICexgc growth 3Y0.42%
ROICexgc growth 5Y-1.8%
ROICexc growth 3Y-6.11%
ROICexc growth 5Y-3.98%
OM growth 3Y-8.34%
OM growth 5Y-1.77%
PM growth 3Y-19.64%
PM growth 5Y-1.18%
GM growth 3Y-2.35%
GM growth 5Y0.69%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.45
Debt/EBITDA 0.33
Cap/Depr 166.16%
Cap/Sales 4.29%
Interest Coverage 81.62
Cash Conversion 88.36%
Profit Quality 124.36%
Current Ratio 3.72
Quick Ratio 3.09
Altman-Z 11.23
F-Score6
WACC10.02%
ROIC/WACC1.2
Cap/Depr(3y)177.3%
Cap/Depr(5y)193.25%
Cap/Sales(3y)4.93%
Cap/Sales(5y)5.41%
Profit Quality(3y)58.49%
Profit Quality(5y)66.28%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
EPS Next Y17.7%
EPS Next 2Y14.8%
EPS Next 3Y14.07%
EPS Next 5Y12.89%
Revenue 1Y (TTM)10.86%
Revenue growth 3Y10.77%
Revenue growth 5Y6.7%
Sales Q2Q%13.26%
Revenue Next Year10.66%
Revenue Next 2Y10.22%
Revenue Next 3Y10.13%
Revenue Next 5Y9.72%
EBIT growth 1Y11.04%
EBIT growth 3Y1.54%
EBIT growth 5Y4.82%
EBIT Next Year25.88%
EBIT Next 3Y16.1%
EBIT Next 5Y14.45%
FCF growth 1Y413.66%
FCF growth 3Y11.88%
FCF growth 5Y15.59%
OCF growth 1Y194.16%
OCF growth 3Y9.4%
OCF growth 5Y8.64%

EDWARDS LIFESCIENCES CORP / EWL.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?

ChartMill assigns a fundamental rating of 7 / 10 to EWL.DE.


What is the valuation status of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.


What is the profitability of EWL stock?

EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 8 / 10.


What are the PE and PB ratios of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 32.04 and the Price/Book (PB) ratio is 4.61.